(2S)-N-[(1S,3S,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanamide ; CAS # 192725-17-0 ;

4,5-Dehydro(pyrimidin-2(1H)-one) Lopinavir ; (S)-N-((2S,4S,5S)-5-(2-(2,6-dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-oxo-3,6-dihydropyrimidin-1(2H)-yl)butanamide ;

Lopinavir Free Amine (HCl) ; (2S)-N-[(1S,3S,4S)-1-Benzyl-4-amino-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin1(2H)-yl]butanamide hydrochloride ; CAS # 192726-05-9 (base) ;

Lopinavir N-Formylaminoalcohol (USP) ; (2S)-N-[(1S,3S,4S)-1-Benzyl-4-(formylamino)-3-hydroxy5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin1(2H)-yl]butanamide ;

Lopinavir Divalinate (USP) ; (2R)-N-[(1S,2S,4S)-1-Benzyl-2-hydroxy-4-[[(2S)-3-methyl2-[2-oxotetrahydro pyrimidin-1(2H)-yl]butanoyl]amino]5-phenylpentyl]-3-methyl-2-[2-oxotetra hydropyrimidin1(2H)-yl]butanamide ;

Sulfolopinavir Enantiomer ; (1R,3R)-1-[(1R)-1-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-2-phenylethyl]-3-[[(2R)-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanoyl]amino]-4-phenylbutyl hydrogen sulfate ;

Lopinavir Phenoxyacetamide (USP) ; N-[(1S,2S,4S)-4-Amino-1-benzyl-2-hydroxy-5-phenylpentyl]-2-(2,6-dimethylphenoxy)acetamide ; CAS # 192725-49-8 ;

Lopinavir N-Formylphenoxyacetamide (USP) ; N-[(1S,2S,4S)-1-Benzyl-4-(formylamino)-2-hydroxy-5-phenylpentyl]-2-(2,6-dimethylphenoxy)acetamide ;

Lopinavir N-Acetylphenoxyacetamide (USP) ; N-[(1S,2S,4S)-(4-Acetylamino)-1-benzyl-2-hydroxy-5-phenylpentyl]-2-(2,6-dimethylphenoxy)acetamide ;

Lopinavir Oxazine (USP) ; N-[(1S)-1-[(4S,6S)-4-Benzyl-2-oxo-1,3-oxazinan-6-yl]-2phenylethyl]-2-(2,6-dimethylphenoxy)acetamide ;

Lopinavir Isomer ; Isolopinavir (USP) ;

Lopinavir 2,4-Phenoxy Isomer (USP) ; Lopinavir 2,4-Dimethylphenoxy Isomer ; (2S)-N-[(1S,3S,4S)-1-Benzyl-4-[[2-(2,4-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2oxotetrahydropyrimidin-1(2H)-yl]butanamide ;

Lopinavir D-Valine Diastereomer (USP) ; (2R)-N-[(1S,3S,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2oxotetrahydropyrimidin-1(2H)-yl]butanamide ; CAS # 1623021-24-8 ;

(Z)-Diacylethendiamine (USP) ; N,N′-(Z)-Ethene-1,2-diylbis[2-(2,6-dimethylphenoxy)acetamide] ;

Lopinavir (2R,4R)-Diastereomer (USP) ; (2S)-N-[(1R,3R,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanamide ;

Lopinavir (4R)-Epimer (USP) ; (2S)-N-[(1S,3R,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2oxotetrahydropyrimidin-1(2H)-yl]butanamide ; CAS # 1798014-18-2 ;

Lopinavir O-Acyl Impurity (USP) ; (1S,3S)-1-[(1S)-1-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-2-phenylethyl]-3-[[(2S)-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanoyl]amino]-4phenylbutyl(2S)-3-methyl-2-[2-oxotetrahydropyrimidin1(2H)-yl]butanoate ;

Lopinavir (2R)-Epimer (USP) ; (2S)-N-[(1R,3S,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2oxotetrahydropyrimidin-1(2H)-yl]butanamide ; CAS # 1217628-64-2 ;

Lopinavir IP Impurity H ; Lopinavir Diamide (USP) ; N-[(1S,2S,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-2-hydroxy-5-phenylpentyl]-2-(2,6dimethylphenoxy)acetamide ; CAS # 667904-94-1 ;

Lopinavir IP Impurity I ; Lopinavir N-Acyl Impurity (USP) ; (2S)-N-[(1S,3S,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-2-[3-[2-(2,6dimethylphenoxy)acetyl]-2-oxotetrahydropyrimidin1(2H)-yl]-3-methylbutanamide ; CAS # 94

Lopinavir O-Phenoxyacetyl (USP) ; (1S,3S)-1-[(1S)-1-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-2-phenylethyl]-3-[[(2S)-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanoyl]amino]-4phenylbutyl2-(2,6-dimethylphenoxy)acetate ; CAS # 943250-65-5 ;

Lopinavir Aminoalcohol Urea (USP) ; N,N′-Bis[(1S,3S,4S)-1-benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]urea ; CAS # 1797024-56-6 ;

(2,6-Dimethylphenoxy)acetic acid ; CAS # 13335-71-2 ;

Lopinavir 4-Hydroxy Analog ; (αS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-4-hydroxy-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidine-acetamide ; CAS # 357275-54-8 ;

(2S)-N-[(1S,3S,4S)-1-Benzyl-4-({[4-(2-{[(1S,2S,4S)-1-benzyl-2-hydroxy-4-{[(2S)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanoyl]amino}-5-phenylpentyl]amino}-2-oxoethyl)-2,6-dimethylphenoxy]acetyl}amino)-3-hydroxy-5-phenylpentyl]-3-methyl-2-(2-oxotet

Lopinavir 4-Oxo Analog ; Lopinavir Metabolite M1 ; (αS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2,4-dioxo-1(2H)-pyrimidineacetamide ; CAS # 192725-39-6 ;

Lopinavir Pentanamide Analog ; (2S,3S)-N-((2S,4S,5S)-5-(2-(2,6-Dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)pentanamide ; CAS # 1132765-59-3 ;

(2S)-N-[(1S,3S,4S)-1-Benzyl-4-{[(2,6-dimethylphenoxy)acetyl]amino}-3-hydroxy-5-phenylpentyl]-4-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)pentanamide ;

(3S,4S,5S,6R)-6-((2S,3S,5S)-2-(2-(2,6-Dimethylphenoxy)acetamido)-5-((S)-3-methyl-2-(2-oxo-tetrahydropyrimidin-1(2H)-yl)butanamido)-1,6-diphenylhexan-3-yloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;

Sulfolopinavir (USP) ; (2S,3S,5S)-2-[2-(2,6-Dimethylphenoxy)acetamido]-5-{(S)-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanamido}-1,6-diphenylhexan-3-yl hydrogen sulfate ;

(2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl)amino-3-hydroxy-5-trifluromethylcarbonylamino-1,6-diphenylhexane ;